Checking Up on GSK in China
When thinking through an FCPA risk assessment, one thing usually not considered adequately is a company’s sales culture. To see the consequences of that, one need look no further than GSK’s corruption troubles in China—but, CW blogger Tom Fox writes, the reforms GSK has implemented with its sales force are ...
Related articles
-
ArticleFormer U.S. clothing business CEO faces 25 years for bribery in Honduras
The former CEO of a Georgia clothing business faces 25 years in prison for bribing Honduran officials to win $10 million in uniform contracts in Honduras, after being caught up in a Department of Justice Anticorruption Task Force.
-
WebcastSept 23 | Decoding DOJ’s Recent Guidance on FCPA Enforcement
Join this timely and practical webinar as we break down the DOJ’s latest FCPA guidance and explore what these developments mean for compliance programs in the real world.
-
ArticleChinese money-laundering networks moved $312B in dirty money through the U.S.
Suspicious activity reports filed by U.S. financial institutions show that Mexican drug cartels and human traffickers are laundering dirty funds through Chinese money laundering networks (CMLNs) operating in the United States, according to the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN).